Find out how AI influences drug discovery, enabling earlier predictions and reducing the risks in clinical development.
Zhongyao Ma, PhD, holds a bachelor’s degree in biology from Shanghai Jiao Tong University and a PhD in genetics and developmental biology from the University of Georgia, U.S. His research focused on ...
This figure illustrates three key applications of AI in antimicrobial drug development: (1) target identification and validation, including novel target discovery, affinity prediction, multi-target ...
Explore the role of transcription factor biology in drug discovery and how it impacts our understanding of disease mechanisms ...
This article and associated images are based on a poster originally authored by Paulina Chorobik, Maciej B. Olszewski, John Vincent and Kirsty Winn and presented at ELRIG Drug Discovery 2025 in ...
LIGAND-AI is a flagship project of the Target 2035 initiative, funded by the Innovative Health Initiative, a public-private partnership (PPP) between the European Union and the European life science ...
Morning Overview on MSN
Nvidia doubles down on AI drug discovery in shocking new push
Nvidia is no longer content to be the chip supplier behind other companies’ biotech ambitions. With a multibillion dollar ...
The Mystra platform, developed over 10 years, offers biopharma partners proven analytical power to turn months of R&D into minutes, dramatically increasing the availability of quality genetic insights ...
The MarketWatch News Department was not involved in the creation of this content. -- Oversubscribed GBP2.5M seed round led by Ahren Innovation Capital -- Strategic collaboration with o2h to progress ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results